Hcw Biologics INC. (HCWB) — SC 13D/A Filings
All SC 13D/A filings from Hcw Biologics INC.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Hing C. Wong Amends HCW Biologics Stake Filing
— Nov 22, 2024 Risk: medium
Hing C. Wong, through HCW Biologics Inc., filed an amendment (No. 1) to their Schedule 13D on November 22, 2024, regarding their holdings in HCW Biologics Inc.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX